Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Engels

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Breast Cancer Research and Treatment|March 13, 2016
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Cardiovascular Research|July 5, 2015
Forced fusion of human ventricular scar cells with cardiomyocytes suppresses arrhythmogenicity in a co-culture modelMarc C Engels, Saïd F A Askar, Wanchana Jangsangthong, et al.
Circulation|May 22, 2015
Fetal Mammalian Heart Generates a Robust Compensatory Response to Cell LossAnthony C Sturzu, Kuppusamy Rajarajan, Derek Passer, et al.
Breast Cancer Research and Treatment|January 25, 2015
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysisC C Engels, A Charehbili, C J H van de Velde, et al.
Scientific Reports|June 29, 2019
Validation of the Fetal Lamb Model of Spina BifidaLuc Joyeux, Alexander C Engels, Johannes Van Der Merwe, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent mannerBegüm Kocatürk, Yascha W Van den Berg, Chris Tieken, et al.
Breast Cancer Research and Treatment|May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancerErik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.
Breast Cancer Research and Treatment|March 15, 2019
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapyA F de Groot, E J Blok, A Charehbili, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Breast Cancer Research and Treatment|March 13, 2016
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysisCharla C Engels, Mandy Kiderlen, Esther Bastiaannet, et al.
Cardiovascular Research|July 5, 2015
Forced fusion of human ventricular scar cells with cardiomyocytes suppresses arrhythmogenicity in a co-culture modelMarc C Engels, Saïd F A Askar, Wanchana Jangsangthong, et al.
Circulation|May 22, 2015
Fetal Mammalian Heart Generates a Robust Compensatory Response to Cell LossAnthony C Sturzu, Kuppusamy Rajarajan, Derek Passer, et al.
Breast Cancer Research and Treatment|January 25, 2015
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysisC C Engels, A Charehbili, C J H van de Velde, et al.
Scientific Reports|June 29, 2019
Validation of the Fetal Lamb Model of Spina BifidaLuc Joyeux, Alexander C Engels, Johannes Van Der Merwe, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent mannerBegüm Kocatürk, Yascha W Van den Berg, Chris Tieken, et al.
Breast Cancer Research and Treatment|May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancerErik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.
Breast Cancer Research and Treatment|March 15, 2019
Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapyA F de Groot, E J Blok, A Charehbili, et al.
Pageof 11